HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4 | -96.7% | 42 | -96.4% | 0.00% | – |
| Q2 2023 | $122 | -5.4% | 1,182 | 0.0% | 0.00% | – |
| Q1 2023 | $129 | -29.1% | 1,182 | -25.9% | 0.00% | – |
| Q4 2022 | $182 | -99.8% | 1,596 | +0.4% | 0.00% | – |
| Q3 2022 | $98,000 | -8.4% | 1,589 | +18.7% | 0.00% | – |
| Q2 2022 | $107,000 | -24.1% | 1,339 | -0.4% | 0.00% | – |
| Q1 2022 | $141,000 | -2.1% | 1,344 | +0.4% | 0.00% | – |
| Q4 2021 | $144,000 | +396.6% | 1,339 | +409.1% | 0.00% | – |
| Q3 2021 | $29,000 | +61.1% | 263 | +40.6% | 0.00% | – |
| Q2 2021 | $18,000 | +5.9% | 187 | 0.0% | 0.00% | – |
| Q1 2021 | $17,000 | +142.9% | 187 | +96.8% | 0.00% | – |
| Q4 2020 | $7,000 | -100.0% | 95 | -100.0% | 0.00% | -100.0% |
| Q3 2020 | $83,469,000 | +834590.0% | 1,074,512 | +292682.6% | 0.25% | – |
| Q3 2019 | $10,000 | – | 367 | – | 0.00% | – |
| Q2 2019 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |